Current World Health Organization (WHO) guidelines recommend screening all PLHIV who have a CD4 count ≤100 cells/μL for cryptococcal antigen (CrAg) to identify those patients with cryptococcal disease who could benefit from preemptive fluconazole treatment prior to the onset of meningitis. The gene discussed is CD4; the disease is infectious meningitis.